Skip to main content Skip to main navigation
Rijksoverheid logo | to homepage of RIVM National Institute for Public Health and the Environment Ministry of Health, Welfare and Sport
  • Nederlands
  • English
RIVM Committed to health and sustainability
  • Home
  • Topics
  • About RIVM
  • Publications
  • International
  • Contact
  • Agenda
  • MijnRIVM
  • Nederlands
  • English
  • Home
  • Search

Search


Search

Fill in your search phrase.

Type

Selecting an option will change the focus to the start of the list.
  • News item (12)
  • Page (8)
  • Blog post (5)
  • Subject (2)
  • Single page (1)

Publication date

Selecting an option will change the focus to the start of the list.
  • (-) December 2024 (13)
  • (-) April 2021 (15)
  • April 2026 (11)
  • March 2026 (19)
  • February 2026 (8)
  • January 2026 (9)
  • December 2025 (21)
  • November 2025 (16)
  • October 2025 (11)
  • September 2025 (19)
  • August 2025 (9)
  • July 2025 (7)
  • June 2025 (8)
  • May 2025 (4)
  • April 2025 (9)
  • March 2025 (3)
  • February 2025 (6)
  • January 2025 (20)
  • November 2024 (7)
  • October 2024 (10)
  • September 2024 (7)
  • August 2024 (5)
  • July 2024 (12)
  • June 2024 (7)
  • May 2024 (9)
  • April 2024 (20)
  • March 2024 (10)
  • February 2024 (7)
  • January 2024 (3)
  • December 2023 (15)
  • November 2023 (6)
  • October 2023 (10)
  • September 2023 (17)
  • August 2023 (4)
  • July 2023 (13)
  • June 2023 (19)
  • May 2023 (4)
  • April 2023 (15)
  • March 2023 (20)
  • February 2023 (20)
  • January 2023 (10)
  • December 2022 (14)
  • November 2022 (25)
  • October 2022 (18)
  • September 2022 (11)
  • August 2022 (10)
  • July 2022 (18)
  • June 2022 (18)
  • May 2022 (10)
  • April 2022 (6)
  • March 2022 (9)
  • February 2022 (7)
  • January 2022 (4)
  • December 2021 (17)
  • November 2021 (9)
  • October 2021 (9)
  • September 2021 (9)
  • August 2021 (6)
  • July 2021 (18)
  • June 2021 (14)
  • May 2021 (15)
  • March 2021 (12)
  • February 2021 (12)
  • January 2021 (7)
  • December 2020 (11)
  • November 2020 (5)
  • October 2020 (9)
  • September 2020 (2)
  • August 2020 (1)
  • July 2020 (4)
  • June 2020 (9)
  • May 2020 (10)
  • April 2020 (10)
  • March 2020 (8)
  • February 2020 (10)
  • January 2020 (6)
  • December 2019 (4)
  • November 2019 (5)
  • October 2019 (11)
  • September 2019 (4)
  • August 2019 (12)
  • July 2019 (4)
  • June 2019 (9)
  • May 2019 (13)
  • April 2019 (8)
  • March 2019 (5)
  • February 2019 (9)
  • January 2019 (10)
  • December 2018 (5)
  • November 2018 (14)
  • October 2018 (12)
  • September 2018 (2)
  • August 2018 (5)
  • July 2018 (6)
  • May 2018 (4)
  • April 2018 (1)
  • March 2018 (5)
  • February 2018 (4)
  • January 2018 (2)
  • December 2017 (12)
  • November 2017 (2)
  • October 2017 (6)
  • September 2017 (12)
  • August 2017 (7)
  • July 2017 (5)
  • June 2017 (1)
  • May 2017 (2)
  • April 2017 (2)
  • March 2017 (4)
  • February 2017 (3)
  • January 2017 (4)
  • December 2016 (8)
  • November 2016 (2)
  • October 2016 (7)
  • August 2016 (1)
  • July 2016 (1)
  • June 2016 (2)
  • March 2016 (15)
  • February 2016 (1)
  • January 2016 (6)
  • December 2015 (7)
  • November 2015 (5)
  • October 2015 (2)
  • August 2015 (1)
  • July 2015 (7)
  • June 2015 (2)
  • May 2015 (1)
  • April 2015 (5)
  • March 2015 (14)
  • February 2015 (4)
  • January 2015 (1)
  • October 2014 (3)
  • August 2014 (3)
  • July 2014 (1)
  • June 2014 (4)
  • May 2014 (1)
  • April 2014 (7)
  • March 2014 (3)
  • February 2014 (10)
  • December 2013 (9)
  • November 2013 (3)
  • October 2013 (1)
  • September 2013 (2)
  • August 2013 (2)
  • July 2013 (2)
  • May 2013 (1)
  • March 2013 (2)
  • December 2012 (1)
  • November 2012 (5)
  • October 2012 (2)
  • July 2012 (5)
  • April 2012 (2)
  • March 2012 (1)
  • February 2012 (8)
  • January 2012 (11)
  • December 2011 (8)
  • September 2011 (6)
  • June 2011 (1)
  • May 2011 (1)
  • March 2011 (2)
  • January 2011 (1)

Topics

Selecting an option will change the focus to the start of the list.
  • International (8)
  • Nanotechnology and advanced materials (5)
  • COVID-19 (4)
  • Corona (1)
  • Incidents and disasters (1)
  • Mental Health (1)
  • Shingles (1)

28 search results

You searched for these word(s): risk assessment
  • New study reveals impact of nanoparticles on placental function and vascular growth - implications for risk assessment

    https://www.rivm.nl/en/weblog/new-study-reveals-impact-of-nanoparticles-on-placental-function-and-vascular-growth

    … to use this model as a standard test for regulatory risk assessment because of ethical concerns surrounding the … placental function and vascular growth - implications for risk assessment …

    Publication date: 12-19-2024
  • Children aged 16-18 years at higher risk for medical reasons will receive first vaccination soon

    https://www.rivm.nl/en/news/children-aged-16-18-years-at-higher-risk-for-medical-reasons-will-receive-first-vaccination

    … born in 2003, 2004 and 2005 who are in the medical high-risk group. The first young people in this group will be … These young people are included in the medical high-risk group that the Health Council has defined for adults. … Children aged 16-18 years at higher risk for medical reasons will receive first vaccination soon …

    Publication date: 04-19-2021
  • Artificial Intelligence/Machine Learning and advanced materials

    https://www.rivm.nl/en/weblog/artificial-intelligencemachine-learning-and-advanced-materials

    … which can potentially be used for optimized hazard and risk assessment of advanced materials. In this way, the … of advanced materials, which is crucial for effective risk assessment. Additionally, ML can assist in establishing … will be a focus on using AI and ML for optimized hazard and risk assessment. This is a positive development, as it …

    Publication date: 12-19-2024
  • People with a medical risk between the ages of 18-60 years invited from early May on

    https://www.rivm.nl/en/news/people-with-medical-risk-between-ages-of-18-60-years-invited-from-early-may-on

    … in the first week of May, people under 60 who are at risk for medical reasons, i.e. the group eligible for the … in this group are prioritised because they have a higher risk of severe illness from COVID-19. This includes people … to respiratory tract infections. People in the medical high-risk groups already received their invitations for COVID-19 …

    Publication date: 04-20-2021
  • EFSA introduces new guidance for evaluating dissolution of nanomaterials in fat

    https://www.rivm.nl/en/weblog/efsa-introduces-new-guidance-for-evaluating-dissolution-of-nanomaterials-in-fat

    … (K OW ) method nanospecific considerations for safety assessments may potentially be waived. However, EFSA also … limitations make it difficult to apply this method to risk assessments of nanoparticles used in applications other than …

    Publication date: 12-19-2024
  • New hold on vaccination with AstraZeneca for people under 60 years

    https://www.rivm.nl/en/news/new-hold-on-vaccination-with-astrazeneca-for-people-under-60-years

    … Pharmacovigilance Centre Lareb. The EMA’s Pharmacovigilance Risk Assessment Committee (PRAC) is currently investigating this … the investigation are expected on Wednesday, 7 April. A new assessment about the use of AstraZeneca will be made at that … in 1961 or later. For people aged 60 or over, the health risk from contracting COVID-19 is much higher than the risk …

    Publication date: 04-02-2021
  • Rethinking regulation: Should nanomaterials be considered biological entities?

    https://www.rivm.nl/en/weblog/rethinking-regulation-should-nanomaterials-be-considered-biological-entities

    … list various well-known challenges regarding the safety assessment of nanomaterials. However, they do not provide … several challenges and difficulties related to  safety assessment of nanomaterials. One example given is that the … that should be addressed in their regulatory safety assessment. However, the perspective does not offer a clear …

    Publication date: 12-19-2024
  • Newsletter on COVID-19 vaccination issue 12 2021

    https://www.rivm.nl/en/covid-19-vaccination/professionals/newsletter/2021/12

    … Vaccination starts for medical high risk groups … for elderly people and for people in the medical high-risk group due to neurological disorders accompanied by … has been made for four categories in the the medical high-risk groups . This applies to people whose immune system is …

    Publication date: 04-02-2021
  • Different vaccine very soon available to people under 60, instead of AstraZeneca

    https://www.rivm.nl/en/news/different-vaccine-very-soon-available-to-people-under-60-instead-of-astrazeneca

    … impact on five groups. This involves people at higher risk for medical reasons who are unable to travel, people … People at higher risk for medical reasons who are unable to travel  This …

    Publication date: 04-13-2021
  • Newsletter on COVID-19 vaccination issue 15, 2021

    https://www.rivm.nl/en/covid-19-vaccination/professionals/newsletter/2021/15

    … born in 2003, 2004 and 2005 who are in a medical high-risk group . The first young people in this group will soon … in the first week of May, people under 60 who are at risk for medical reasons , i.e. the group eligible for the … This was the conclusion reached by the Pharmacovigilance Risk Assessment Committee (PRAC) of the European Medicines …

    Publication date: 04-22-2021
  • Newsletter on COVID-19 vaccination issue 14 2021

    https://www.rivm.nl/en/covid-19-vaccination/professionals/newsletter/2021/14

    … 60 has a direct impact on five groups: people at higher risk for medical reasons who are unable to travel, people … can be attributed to the vaccine. The Pharmacovigilance Risk Assessment Committee (PRAC) of the European Medicines Agency … in 2003, 2004 and 2005) who are in one of the medical high-risk groups . This vaccine has been approved for people aged …

    Publication date: 04-20-2021
  • Newsletter on COVID-19 vaccination issue 13 2021

    https://www.rivm.nl/en/covid-19-vaccination/professionals/newsletter/2021/13

    … This was the conclusion reached by the Pharmacovigilance Risk Assessment Committee (PRAC) of the European Medicines Agency …

    Publication date: 04-12-2021
  • Healthy and Active Living Agreement encourages working together to improve health

    https://www.rivm.nl/en/news/healthy-and-active-living-agreement-encourages-working-together-to-improve-health

    … people who are more likely to fall and to reduce the risk of accidents. RIVM has been asked to monitor the … which professionals are qualified to carry out the fall risk factor assessment (GP practices, physiotherapists or occupational …

    Publication date: 12-10-2024
  • RIVM advises consumers to check N-acetylcysteine content of food supplements

    https://www.rivm.nl/en/news/rivm-advises-consumers-to-check-n-acetylcysteine-content-of-food-supplements

    … effects that can include gastrointestinal symptoms. Safety assessment At the request of the Dutch Ministry of Health, …

    Publication date: 12-13-2024
  • Sewage as an indicator of health

    https://www.rivm.nl/en/covid-19/sewage/indicator-health

    … & Hepatology. SARS-CoV-2 in wastewater: potential health risk, but also data source. Article on …

    Publication date: 04-21-2021
  • GPs will invite under-60s with Down's syndrome or morbid obesity for GGD vaccination

    https://www.rivm.nl/en/news/gps-will-invite-under-60s-with-downs-syndrome-or-morbid-obesity-for-ggd-vaccination

    … People in these two groups have a higher risk of serious illness from COVID-19. Many of them have … receive their vaccination from week 17 on.  Other medical risk groups The other groups at higher risk for medical reasons will be vaccinated via other …

    Publication date: 04-16-2021
  • Vaccination with AstraZeneca continues for people aged 60 years and older

    https://www.rivm.nl/en/news/vaccination-with-astrazeneca-continues-for-people-aged-60-years-and-older

    … People under 60 years old who are in the medical high-risk groups; that means people with Down’s Syndrome, people … under 60. Progress on vaccination of the elderly, high-risk patients and care workers Vaccinating vulnerable target groups (the elderly, patients at higher risk for medical reasons, and care workers) as soon as …

    Publication date: 04-09-2021
  • Shingles

    https://www.rivm.nl/en/shingles

    … reactivated. At that point, they may develop shingles. The risk is highest among people over 60. Shingles is usually … or the fluid from them. It is good to know that the risk of getting chickenpox from someone with shingles is much lower than the risk of getting chickenpox from someone with chickenpox. …

    Publication date: 12-16-2024
  • Shigellosis

    https://www.rivm.nl/en/shigellosis

    … Anyone can get shigellosis. Some people have a higher risk of getting the disease: People travelling to warm … Men who have sex with men. Some people have a higher risk of becoming seriously ill from shigellosis: People who … getting shigellosis. Good hygiene can help to minimise the risk: Wash your hands regularly: Before eating and before …

    Publication date: 12-04-2024
  • Shingles vaccination

    https://www.rivm.nl/en/shingles/shingles-vaccination

    … and adults who are in one or more of the following medical risk groups: people who recently had a stem cell transplant, … against shingles with Zostavax is not recommended in the risk groups listed above, because this vaccine contains live … by insurance for people in one or more of the medical risk groups. You will need a doctor’s letter  to confirm …

    Publication date: 12-16-2024

Pagination

  • Current page 1
  • Page 2
  • › Next
  • » Last

Service

  • Contact
  • Information for the press
  • Working for RIVM
  • Complaints
  • Submitting WOO requests to RIVM
  • Doing business with RIVM
  • Huisregels sociale media

About this site

  • Cookies
  • Privacy
  • Accessibility
  • Disclaimer and copyright
  • Coordinated Vulnerability Disclosure
  • Website archive

Languages

  • English
  • Nederlands

Follow us

  • RIVM Newsletters
  • RSS feed
  • X Twitter
  • Facebook
  • LinkedIn
  • Youtube
  • Instagram
  • Mastodon